1.Diagnostic Usefulness of Transrectal Ultrasound Compared with Transvaginal Ultrasound Assessment in Young Korean Women with Polycystic Ovary Syndrome.
Da Eun LEE ; So Yun PARK ; Sa Ra LEE ; Kyungah JEONG ; Hye Won CHUNG
Journal of Menopausal Medicine 2015;21(3):149-154
OBJECTIVES: To determine the diagnostic performance of transrectal ultrasound in virgin patients with polycystic ovary syndrome (PCOS) by receiver operating characteristic (ROC) curve analysis, compared with conventional transvaginal ultrasound assessment. METHODS: Ultrasound examinations were performed in 963 Korean women, with transvaginal transducers in 677 women and transrectal transducers in 286 women at Ewha Womans University Mokdong Hospital. Transvaginal ultrasound examinations were performed in 494 normal control women and 183 PCOS patients according to National Institutes of Health (NIH) PCOS diagnostic criteria. In virgin patients, transrectal ultrasound examinations were performed in 141 normal control women and 145 PCOS patients. ROC curves were calculated for ovarian volume and follicle number. RESULTS: By transvaginal ultrasound examination, the ovarian volume showed an area under the ROC curve (AURC) of 0.838. An ovarian volume decision threshold > 7 cm3 had a sensitivity of 73.0% and a specificity of 84.2% for the diagnosis of PCOS. The follicle number showed an AURC of 0.886. A follicle number decision threshold > or = 9 had a sensitivity of 78.6% and a specificity of 87.2% for the diagnosis of PCOS. By transrectal ultrasound examination, the ovarian volume and the follicle number showed AURCs of 0.815 as same thresholds with a sensitivity of 67.2% and 66.4%, respectively and a specificity of 86.8% each. Ovarian volume and follicle number by transvaginal and transrectal ultrasound assessment had a high diagnostic power for PCOS screening. CONCLUSION: Transrectal ultrasound assessment is as effective as conventional transvaginal ultrasound for the detection of PCOS in virgin patients.
Diagnosis
;
Female
;
Humans
;
Mass Screening
;
National Institutes of Health (U.S.)
;
Polycystic Ovary Syndrome*
;
ROC Curve
;
Sensitivity and Specificity
;
Transducers
;
Ultrasonography*
2.Comparison of the Effects of General and Pregnant Women’s Dentifrices on the Removal of the Dental Plaque
Ye-Eun KIM ; Seong-Eun KO ; Da-Eun SA ; Ji-Eun LEE ; Se-Yoon JEON ; Do-Seon LIM
Journal of Dental Hygiene Science 2020;20(4):245-251
Background:
This study tries to compare and analyze the removal effect of dental plaque of general dentifrice and pregnant women’s dentifrice and quantify the results to provide basic data so that consumers can make reasonable choices when purchasing dentifrice, and also increase interest in the dental plaque.
Methods:
After forming a dental plaque (carbohydrate porridge) on the labial surface of the bovine teeth, a disclosing agent was applied. Then the same experimenter brushed the surface of the bovine teeth using an electric toothbrush and took photographs using a DSLR camera. Thereafter, the residual amount of dental plaque was analyzed using the ImageJ program, and SPSS 26.0 was used for statistical processing.
Results:
The average residual amount of dental plaque using the general dentifrice was 11.71% for Perio, 9.45% for Cliden, and 8.47% for 2080, and the average residual amount for the three types was approximately 9.88%. The average residual amount of dental plaque of pregnant women’s dentifrice was 13.95% for Jeninmothers, 12.53% for Tntnmoms, and 12.63% for Mommiracle, and the average residual amount of the three types was approximately 13.04%. On comparing the average residual amount of dental plaque between general and pregnant women’s dentifrices, it was observed to be 3.16% higher for the latter. However, the results were not statistically significant.
Conclusion
According to the research results, there was no significant difference in removal effects of general dentifrice and pregnant women’s dentifrice. In addition, when a pregnant woman uses the right toothbrushing method with pregnant women’s dentifrice, it can prevent or inhibit the progression of the gestational periodontal disease. Therefore, we recommend pregnant women to use pregnant women’s dentifrices.
3.Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome.
Da Eun LEE ; Soo Yeon PARK ; So Yun PARK ; Sa Ra LEE ; Hye Won CHUNG ; Kyungah JEONG
Journal of Menopausal Medicine 2014;20(3):104-110
OBJECTIVES: The aim of this study was to investigate the clinical and biochemical profiles according to homeostasis model assessment of insulin resistance (HOMA-IR) in Korean polycystic ovary syndrome (PCOS) patients. METHODS: In 458 PCOS patients diagnosed by the Rotterdam European Society for Human Reproduction and Embryology (ESHRE) criteria, measurements of somatometry, blood test of hormones, glucose metabolic and lipid profiles, and transvaginal or transrectal ultrasonogram were carried out. HOMA-IR was then calculated and compared with the clinical and biochemical profiles related to PCOS. The patients were divided into 4 groups by quartiles of HOMA-IR. RESULTS: The mean level of HOMA-IR was 2.18 +/- 1.73. Among the four groups separated according to HOMA-IR, body weight, body mass index (BMI), waist-to-hip ratio (WHR), triglyceride (TG), total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, lipid accumulation product (LAP) index, high-sensitivity C-reactive protein (hs-CRP), Apoprotein B, free testosterone, and sex hormone binding globulin (SHBG) were found to be significantly different. TG, LAP index, glucose metabolic profiles, and hs-CRP were positively correlated with HOMA-IR after adjustment for BMI. CONCLUSION: Our results suggest that the clinical and biochemical profiles which are applicable as cardiovascular risk factors are highly correlated with HOMA-IR in Korean women with PCOS.
Apoproteins
;
Body Mass Index
;
Body Weight
;
C-Reactive Protein
;
Cardiovascular Diseases
;
Cholesterol
;
Embryology
;
Female
;
Glucose
;
Hematologic Tests
;
Homeostasis*
;
Humans
;
Insulin Resistance
;
Lipid Accumulation Product
;
Lipoproteins
;
Metabolome
;
Polycystic Ovary Syndrome*
;
Reproduction
;
Risk Factors
;
Sex Hormone-Binding Globulin
;
Testosterone
;
Triglycerides
;
Ultrasonography
;
Waist-Hip Ratio
4.Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody.
Da Yeon JUNG ; Eun Young KIM ; Sung Yeon JOO ; Jae Berm PARK ; Cheol MOON ; Sa Hyun KIM ; Eun Young SIM ; Jae Won JOH ; Choon Hyuck KWON ; Ghee Young KWON ; Sung Joo KIM
Experimental & Molecular Medicine 2008;40(1):1-10
Pancreatic islet transplantation can correct the abnormal glucose metabolism of Type 1 diabetes. Although immunosuppressants greatly reduce the acute rejection rate in transplant patients, the long-term side effects can be debilitating. Therefore, researchers are seeking to develop new immunosuppressive regimens that induce maximal levels of immunosuppression with minor side effects. Rosmarinic acid (Ros A) is a secondary metabolite of certain herbs and has multiple biological activities, including anti-inflammatory effects. Here, we have investigated whether treatment of mice with a combination of Ros A and anti-CD154 monoclonal antibody (MR1) improves islet allograft survival in a murine model. After transplantation, the mice were treated with either Ros A, MR1, or both (the "double" treatment). Allograft survival was prolonged in the double-treated animals compared to animals that received only Ros A or MR1. As is the case with the single-treated animals at 15 days after transplantation, the double-treated recipients did not display a significant decrease in the expression of cytokines or the population of activated T cells. Infiltrating CD3+ T cells were reduced in the MR1- or double therapy relative to control or RosA group. However, at the same time point, double-treated graft showed fewer apoptotic cells and increased expression of insulin and glucagons, compared to the single-treatment groups. Furthermore, long-term (>150 days) allografts that were received with double therapy exhibited larger islet clusters and contained more insulin- and glucagon-positive cells, relative to the MR1-treated grafts. In conclusion, treatment with both Ros A and MR1 has a synergistic effect in murine islet allotransplantation.
Animals
;
Antibodies, Monoclonal/*pharmacology
;
Apoptosis/drug effects
;
CD40 Ligand/*immunology
;
Cinnamates/*pharmacology
;
Cytokines/biosynthesis
;
Depsides/*pharmacology
;
Diabetes Mellitus, Experimental
;
Flow Cytometry
;
Glucose/metabolism
;
Glucose Tolerance Test
;
Graft Survival/*drug effects
;
In Situ Nick-End Labeling
;
Injections, Intraperitoneal
;
Islets of Langerhans/drug effects/pathology
;
*Islets of Langerhans Transplantation
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Time Factors
;
Transplantation, Homologous